Related references
Note: Only part of the references are listed.Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress
Severine Gratia et al.
CARDIOVASCULAR RESEARCH (2012)
Prior starvation mitigates acute doxorubicin cardiotoxicity through restoration of autophagy in affected cardiomyocytes
Tomonori Kawaguchi et al.
CARDIOVASCULAR RESEARCH (2012)
p53 Opens the Mitochondrial Permeability Transition Pore to Trigger Necrosis
Angelina V. Vaseva et al.
CELL (2012)
Effects of doxorubicin cancer therapy on autophagy and the ubiquitin-proteasome system in long-term cultured adult rat cardiomyocytes
Polychronis Dimitrakis et al.
CELL AND TISSUE RESEARCH (2012)
Carnitine and Acylcarnitines
Stephanie E. Reuter et al.
CLINICAL PHARMACOKINETICS (2012)
Exercise as a beneficial adjunct therapy during Doxorubicin treatment-Role of mitochondria in cardioprotection
Antonio Ascensao et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
The Neglected Significance of Antioxidative Stress
B. Poljsak et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2012)
Mitochondrionopathy Phenotype in Doxorubicin-Treated Wistar Rats Depends on Treatment Protocol and Is Cardiac-Specific
Goncalo C. Pereira et al.
PLOS ONE (2012)
The complexity of cardiolipin in health and disease
Steven M. Claypool et al.
TRENDS IN BIOCHEMICAL SCIENCES (2012)
Chronic Anthracycline Cardiotoxicity: Molecular and Functional Analysis with Focus on Nuclear Factor Erythroid 2-Related Factor 2 and Mitochondrial Biogenesis Pathways
Eduard Jirkovsky et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death
Andrey V. Kuznetsov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Alpha-tocopheryl succinate enhances doxorubicin-induced apoptosis in human gastric cancer cells via promotion of doxorubicin influx and suppression of doxorubicin efflux
Xuguang Zhang et al.
CANCER LETTERS (2011)
Mitochondrial permeability transition in Ca2+-dependent apoptosis and necrosis
Andrea Rasola et al.
CELL CALCIUM (2011)
Acute exercise protects against calcium-induced cardiac mitochondrial permeability transition pore opening in doxorubicin-treated rats
Antonio Ascensao et al.
CLINICAL SCIENCE (2011)
Drug-induced Cardiac Mitochondrial Toxicity and Protection: From Doxorubicin to Carvedilol
Goncalo C. Pereira et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Cysteine/cystine redox signaling in cardiovascular disease
Young-Mi Go et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Caloric Restriction Mimetic 2-Deoxyglucose Antagonizes Doxorubicin-induced Cardiomyocyte Death by Multiple Mechanisms
Kai Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Oxidative Stress and Myocardial Gene Alterations Associated with Doxorubicin-Induced Cardiotoxicity in Rats Persist for 2 Months after Treatment Cessation
Carole Richard et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
p53 Regulates Oxidative Stress-Mediated Retrograde Signaling: A Novel Mechanism for Chemotherapy-Induced Cardiac Injury
Joyce M. Velez et al.
PLOS ONE (2011)
Cardiomyocyte Specific Ablation of p53 Is Not Sufficient to Block Doxorubicin Induced Cardiac Fibrosis and Associated Cytoskeletal Changes
Tiam Feridooni et al.
PLOS ONE (2011)
Early effects of doxorubicin in perfused heart: transcriptional profiling reveals inhibition of cellular stress response genes
Malgorzata Tokarska-Schlattner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2010)
Glutamine regulation of doxorubicin accumulation in hearts versus tumors in experimental rats
Valentina K. Todorova et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Doxorubicin Cardiomyopathy
Kanu Chatterjee et al.
CARDIOLOGY (2010)
Pathology of late-onset anthracycline cardiomyopathy
Bob N. Bernaba et al.
CARDIOVASCULAR PATHOLOGY (2010)
Sub-chronic administration of doxorubicin to Wistar rats results in oxidative stress and unaltered apoptotic signaling in the lung
Nuno G. Machado et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2010)
Anthracycline Cardiomyopathy Is Mediated by Depletion of the Cardiac Stem Cell Pool and Is Rescued by Restoration of Progenitor Cell Function
Antonella De Angelis et al.
CIRCULATION (2010)
Inhibition of gene expression of heart fatty acid binding protein and organic cation/carnitine transporter in doxorubicin cardiomyopathic rat model
Mohamed M. Sayed-Ahmed et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Oral Glutamine Protects against Acute Doxorubicin-Induced Cardiotoxicity of Tumor-Bearing Rats
Valentina K. Todorova et al.
JOURNAL OF NUTRITION (2010)
Myocardial Fatty Acid Metabolism in Health and Disease
Gary D. Lopaschuk et al.
PHYSIOLOGICAL REVIEWS (2010)
Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy
Rui A. Carvalho et al.
TOXICOLOGY (2010)
Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro
Partha Mukhopadhyay et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2
Paolo Spallarossa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Cardiomyocyte death in doxorubicin-induced cardiotoxicity
Yi-Wei Zhang et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2009)
The mitochondrial permeability transition pore and ischemia-reperfusion injury
Christopher P. Baines
BASIC RESEARCH IN CARDIOLOGY (2009)
Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs
Neil Ashley et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
The role of the mitochondrial permeability transition pore in heart disease
Andrew P. Halestrap et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2009)
Doxorubicin Inactivates Myocardial Cytochrome c Oxidase in Rats: Cardioprotection by Mito-Q
Karunakaran Chandran et al.
BIOPHYSICAL JOURNAL (2009)
Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts
Vilma A. Sardao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Respiratory chain deficiency precedes the disrupted calcium homeostasis in chronic doxorubicin cardiomyopathy
Dirk Lebrecht et al.
CARDIOVASCULAR PATHOLOGY (2009)
Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets
Vilma A. Sardao et al.
CELL BIOLOGY AND TOXICOLOGY (2009)
Acute Doxorubicin Cardiotoxicity Is Associated With p53-Induced Inhibition of the Mammalian Target of Rapamycin Pathway
Wuqiang Zhu et al.
CIRCULATION (2009)
Doxorubicin: The Good, the Bad and the Ugly Effect
Cristina Carvalho et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Adriamycin-induced autophagic cardiomyocyte death plays a pathogenic role in a rat model of heart failure
Lihe Lu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
The molecular composition of the mitochondrial permeability transition pore
Christopher P. Baines
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity
Masashi Yoshida et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
What is the mitochondrial permeability transition pore?
Andrew P. Halestrap
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Mitochondrial Permeability Transition Pore Opening as a Promising Therapeutic Target in Cardiac Diseases
Sabzali Javadov et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Metabonomic identification of novel biomarkers in doxorubicin cardiotoxicity and protective effect of the natural antioxidant oleuropein
Ioanna Andreadou et al.
NMR IN BIOMEDICINE (2009)
Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage
Yasuhiro Maejima et al.
AGING CELL (2008)
Radical-free biology of oxidative stress
Dean P. Jones
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes
Jiahao Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Heat Shock Protein 20 Interacting With Phosphorylated Akt Reduces Doxorubicin-Triggered Oxidative Stress and Cardiotoxicity
Guo-Chang Fan et al.
CIRCULATION RESEARCH (2008)
Doxorubicin increases the susceptibility of brain mitochondria to Ca2+-induced permeability transition and oxidative damage
Susana Cardoso et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Acute exercise protects against doxorubicin cardiotoxicity
Karen Y. Wonders et al.
INTEGRATIVE CANCER THERAPIES (2008)
The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition
Anna W. C. Leung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A Mouse Model for Juvenile Doxorubicin-Induced Cardiac Dysfunction
Wuqiang Zhu et al.
PEDIATRIC RESEARCH (2008)
Beneficial effects of exercise on muscle mitochondrial function in diabetes mellitus
Jose A. Lumini et al.
SPORTS MEDICINE (2008)
Mechanism of protection of moderately diet restricted rats against doxorubicin-induced acute cardiotoxicity
Mayurranjan S. Mitra et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death
Christopher P. Baines et al.
NATURE CELL BIOLOGY (2007)
Adriamycin-induced myocardial toxicity: New solutions for an old problem?
Delia Outomuro et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Adriamycin-induced oxidative mitochondrial cardiotoxicity
J. M. Berthiaume et al.
CELL BIOLOGY AND TOXICOLOGY (2007)
Persistent alterations to the gene expression profile of the heart subsequent to chronic doxorubicin treatment
Jessica M. Berthiaume et al.
CARDIOVASCULAR TOXICOLOGY (2007)
Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer
Edit Bardi et al.
PATHOLOGY & ONCOLOGY RESEARCH (2007)
Improved postischemic function following acute exercise is not mediated by nitric oxide synthase in the rat heart
Ryan P. Taylor et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
New iron chelators in anthracycline-induced cardiotoxicity
Helena Kaiserova et al.
CARDIOVASCULAR TOXICOLOGY (2007)
Dexrazoxane: how it works in cardiac and tumor cells. Is it a prodrug or is it a drug?
Brian B. Hasinoff et al.
CARDIOVASCULAR TOXICOLOGY (2007)
Doxorubicin-induccd cardiomyopathy from the cardiotoxic mechanisms to management
Genzou Takemura et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2007)
Protective effects of carvedilol against anthracycline-induced cardiomyopathy
Nihat Kalay et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin
H. Kaiserova et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Doxorubicin in experimental and clinical heart failure
Stefan Christiansen et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2006)
Attenuation of doxorubicin-induced contractile and mitochondrial dysfunction in mouse heart by cellular glutathione peroxidase
Ye Xiong et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo
Michihiko Ueno et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2006)
Depletion of adenine nucleotide translocator protein in heart mitochondria from doxorubicin-treated rats- Relevance for mitochondrial. dysfunction
PJ Oliveira et al.
TOXICOLOGY (2006)
Doxorubicin-induced thiol-dependent alteration of cardiac mitochondrial permeability transition and respiration
PJ Oliveira et al.
BIOCHEMISTRY-MOSCOW (2006)
Exercise training attenuates acute doxorubicin-induced cardiac dysfunction
AJ Chicco et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
Multiple actions of pifithrin-alpha on doxorubicin- induced apoptosis in rat myoblastic H9c2 cells
Chu Chang Chua et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
New insights into doxorubicin-induced cardiotoxicity: The critical role of cellular energetics
Malgorzata Tokarska-Schlattner et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin
Malgorzata Tokarska-Schlattner et al.
COMPTES RENDUS BIOLOGIES (2006)
Exposure to anthracyclines during childhood causes cardiac injury
Steven E. Lipshultz
SEMINARS IN ONCOLOGY (2006)
Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin
D Lebrecht et al.
JOURNAL OF PATHOLOGY (2005)
Chemotherapy and cardiotoxicity in older breast cancer patients: A population-based study
JJ Doyle et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis
A Ascensao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Acute toxicity of doxorubicin on isolated perfused heart: response of kinases regulating energy supply
M Tokarska-Schlattner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Modulation of sarcoplasmic reticulum Ca2+ release by glycolysis in cat atrial myocytes
J Kockskämper et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
Endurance training attenuates doxorubicin-induced cardiac oxidative damage in mice
A Ascensao et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2005)
Susceptibility of the heart to ischaemia-reperfusion injury and exercise-induced card ioprotection are sex-dependent in the rat
DA Brown et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death
T Nakagawa et al.
NATURE (2005)
Induction of caspase-independent apoptosis in H9c2 cardiomyocytes by adriamycin treatment
HJ Youn et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)
Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction
JM Berthiaume et al.
CARDIOVASCULAR TOXICOLOGY (2005)
Pifithrin-α protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice
XW Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore
JE Kokoszka et al.
NATURE (2004)
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia
SE Lipshultz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Doxorubicin treatment in vivo activates caspase-12 mediated cardiac apoptosis in both male and female rats
YM Jang et al.
FEBS LETTERS (2004)
Cardiovascular complications of cancer therapy - Diagnosis, pathogenesis, and management
ETH Yeh et al.
CIRCULATION (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity
PJ Oliveira et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro
P Spallarossa et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
The oral iron chelator ICL670A (deferasirox) does not protect myocytes against doxorubicin
BB Hasinoff et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
Time-dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy
D Lebrecht et al.
CIRCULATION (2003)
Doxorubicin-induced cardiac mitochondrionopathy
KB Wallace
PHARMACOLOGY & TOXICOLOGY (2003)
Pregnancy outcome in women treated with doxorubicin for childhood cancer
J Bar et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
Exercise improves postischemic function in aging hearts
JW Starnes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Pifithrin-α promotes p53-mediated apoptosis in JB6 cells
A Kaji et al.
MOLECULAR CARCINOGENESIS (2003)
Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease -: A statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity)
PD Thompson et al.
CIRCULATION (2003)
Effect of L-carnitine supplementation on cardiac carnitine palmitoyltransferase activities and plasma carnitine concentrations in adriamycin-treated rats
HR Yoon et al.
PEDIATRIC RESEARCH (2003)
Amlodipine inhibits doxorubicin-induced apoptosis in neonatal rat cardiac myocytes
S Yamanaka et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Anthracycline-induced suppression of GATA-4 transcription factor: Implication in the regulation of cardiac myocyte apoptosis
Y Kim et al.
MOLECULAR PHARMACOLOGY (2003)
Doxorubicin induces early lipid peroxidation associated with changes in glucose transport in cultured cardiomyocytes
S Hrelia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2002)
Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy
DL Santos et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2002)
Antioxidant nutrients and adriamycin toxicity
JL Quiles et al.
TOXICOLOGY (2002)
Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore
GP McStay et al.
BIOCHEMICAL JOURNAL (2002)
Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis
PS Green et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update - Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases
TA Pearson et al.
CIRCULATION (2002)
Is there a threshold intensity for aerobic training in cardiac patients?
DP Swain et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2002)
Melatonin as an effective protector against doxorubicin-induced cardiotoxicity
XW Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Dietary fish oil and vitamin E enhance doxorubicin effects in P388 tumor-bearing mice
QY Liu et al.
LIPIDS (2002)
Frequency and risk factors of anthracycline-induced clinical heart failure in children:: a systematic review
LCM Kremer et al.
ANNALS OF ONCOLOGY (2002)
Serum lipid and fatty acid profiles in adriamycin-treated rats after administration of L-carnitine
YM Hong et al.
PEDIATRIC RESEARCH (2002)
Multiple interference of anthracyclines with mitochondrial creatine kinases: Preferential damage of the cardiac isoenzyme and its implications for drug cardiotoxicity
M Tokarska-Schlattner et al.
MOLECULAR PHARMACOLOGY (2002)
Bcl-xl reduces doxorubicin-induced myocardial damage but fails to control cardiac gene downregulation
K Kunisada et al.
CARDIOVASCULAR RESEARCH (2002)
Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs
R Danesi et al.
CLINICAL PHARMACOKINETICS (2002)
Nuclear magnetic resonance study of doxorubicin binding to cardiolipin containing magnetically oriented phospholipid bilayers
MA Parker et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
L-carnitine prevents increase in diastolic [Ca2+] induced by doxorubicin in cardiac cells
A Mijares et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia - Analysis of the clinico-pathological aspects of documented acute anthracycline-induced cardiotoxicity inpatients treated for acute leukaemia at the University Hospital of Zurich, Switzerland, between 1990 and 1996
H Dazzi et al.
ANNALS OF ONCOLOGY (2001)
The importance of glycolytically-derived ATP for the Na+/H+ exchange activity in guinea pig ventricular myocytes
S Sugiyama et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2001)
Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen - Role of reactive oxygen and nitrogen species
S Kotamraju et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Apoptosis in rat cardiac myocytes induced by Fas ligand: Priming for Fas-mediated apoptosis with doxorubicin
M Yamaoka et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Adriamycin-induced heart failure: mechanisms and modulation
P Singal et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2000)
Antioxidant action, of the antihypertensive drug, carvedilol, against lipid peroxidation
N Noguchi et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Cardiotoxicity of chemotherapeutic agents - Incidence, treatment and prevention
VB Pai et al.
DRUG SAFETY (2000)
Carvedilol inhibits the exogenous NADH dehydrogenase in rat heart mitochondria
PJ Oliveira et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
Molecular basis of anthracycline-induced cardiotoxicity and its prevention
MS Horenstein et al.
MOLECULAR GENETICS AND METABOLISM (2000)
Cardiotoxicity of doxorubicin and other anthracycline derivatives
D Jain
JOURNAL OF NUCLEAR CARDIOLOGY (2000)
Share Paper
